Carole Mitnick, professor of Global Health and Social Medicine, graduated cum laude from the University of Rochester in 1988 with a B.A. in political science and French. She spent 1986-1987 in Paris, France, studying at L’Institut d’Etudes Politiques and L’Université de Paris IV. In 1996, she received a masters in international health epidemiology and ecology from the Harvard School of Public Health, and in 2001 she completed a doctor of science degree in international health epidemiology and ecology, also at the Harvard School of Public Health.


Salmaan Keshavjee is a professor in the Department of Global Health and Social Medicine and Department of Medicine at Harvard Medical School, and director of Harvard Medical School’s Center for Global Health Delivery–Dubai. He also serves as a physician in the Division of Global Health Equity at the Brigham and Women’s Hospital. He conducted doctoral research in medical anthropology at Harvard University on the health transition in post-Soviet Tajikistan. He has worked with the Division of Global Health Equity and the Boston-based non-profit, Partners In Health, on the implementation of a multidrug-resistant tuberculosis (MDR-TB) treatment program in Tomsk, Russia. Between 2006 and 2008, Keshavjee set up the first community-based treatment program to treat patients co-infected with HIV and MDR-TB in Lesotho. Between 2007 and 2010, Dr. Keshavjee served as the chair of the Green Light Committee Initiative, a Stop TB Partnership/WHO initiative which helped countries gain access to high-quality second-line anti-TB drugs so they can provide treatment for people with MDR-TB. He is a co-founder of Advance Access & Delivery, a non-profit committed to addressing critical challenges in access to medicines and the delivery of comprehensive healthcare, particularly for economically and socially marginalized groups.

Date & Time

Wednesday, December 2, 2020 at 12:00pm EDT

Zoom Link

https://harvard.zoom.us/j/95261912030? pwd=M2xMekhKb2w1enVMUkpXckxPMG13UT09

Add to your Calendar